Skip to content

The effectiveness of cognitive-behavioral therapy on the optimism of family caregivers of cancer patients

The effectiveness of cognitive-behavioral therapy on the optimism of family caregivers of cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241229064210N2
Enrollment
80
Registered
2025-03-15
Start date
2025-02-11
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention group: The training in the test group will be held in the form of 9 sessions of 60 to 90 minutes according to the protocol by a psychotherapist. It is worth noting that after the study is

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age 18-70 years Having the ability to read, write, and speak Persian Having a family relationship and the main role of caring for the patient Not having a specific disease or unstable medical condition that would prevent the patient from being able to care for a cancer patient Not having a diagnosis of cancer in the past four years Not reporting cognitive impairment by the individual Not having regular treatment by a psychologist or psychiatrist Informed consent Access to cyberspace Not having been hospitalized in a psychiatric ward with a diagnosis of mental disorders in the past two years Not having a history of suicide Not receiving treatment with antipsychotic and anticonvulsant medications Not having substance abuse or dependence in the past year Not simultaneously caring for other family members due to physical or mental illness at home or in the hospital by the patient's main companion Not having previous or current participation in other educational programs in the field of psychology

Exclusion criteria

Exclusion criteria: Absence of more than two sessions in the program Unwillingness or inability to continue participating in the study Death of the patient with cancer

Design outcomes

Primary

MeasureTime frame
Optimism. Timepoint: Before the start of the study and one month later. Method of measurement: Scheier and Carver Optimism Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Amouzeshi

Birjand University of Medical Sciences

amouzeshiz9039@gmail.com+98 56 3275 3138

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026